What is Subcutaneous immune globulin?

Category: Prescription Drugs

Most popular types: Hizentra CUVITRU HyQvia Show all

false

Subcutaneous immune globulin is used in the treatment of primary humoral immunodeficiency.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Common variable immunodeficiency disorder 24 19
Hypogammaglobulinemia 9 13
Specific antibody deficiency 3 1
Chronic inflammatory demyelinating polyneuropathy 2 1
IgG deficiency 2 1
Immune system weak 1 0

Show all 7 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
2
Moderate
8
Mild
17
None
7

Commonly reported side effects and conditions associated with Subcutaneous immune globulin

Side effect Patients
Fatigue 3
Headaches 3
Chills 2
Diarrhea 2
Injection site pain 2
Pain 2

Show all 31 reported side effects

Dosages

Based on patients currently taking Subcutaneous immune globulin

Dosage Patients
200 mg weekly 4
10 g weekly 2
10 mg weekly 2
15 mL every other week 1
36 g monthly 1
17 mg every other week 1
13 g weekly 1
13.5 mg weekly 1
40 mg every other week 1
50 mL weekly 1

See all 13 dosages

Why patients stopped taking Subcutaneous immune globulin

Multiple reasons could be selected

Reason Patients
Side effects too severe 2
Change in health plan coverage 1
Did not seem to work 1
Expense 1
Other 1
See all 3 patients who've stopped taking Subcutaneous immune globulin

Duration

Currently taking Subcutaneous immune globulin

Duration Patients
Less than 1 month 2
6 months - 1 year 3
1 - 2 years 1
2 - 5 years 5
5 - 10 years 5
10 years or more 1

Stopped taking Subcutaneous immune globulin

Duration Patients
1 - 6 months 1
2 - 5 years 2
Adherence
Adherence Evaluations
Always 27
Usually 6
Sometimes 0
Never taken as prescribed 1
Burden
Burden Evaluations
Very hard to take 5
Somewhat hard to take 14
A little hard to take 4
Not at all hard to take 11
Cost per month
Cost per month Evaluations
$200+ 5
$100-199 0
$50-99 3
$25-49 0
< $25 11
Not specified 15

What people switch to and from

Patients started taking Subcutaneous immune globulin after stopping:

Treatment Patients
Intravenous Immunoglobulin (IVIG) (Gammaglobulin (IVIg)) 12
Subcutaneous immune globulin (Hizentra) 1

Patients stopped taking Subcutaneous immune globulin and switched to:

Treatment Patients
Intravenous Immunoglobulin (IVIG) (Gammaglobulin (IVIg)) 1
Subcutaneous immune globulin (Hizentra) 1
Last updated:
There are no evaluations for Subcutaneous immune globulin.